Drug
68Ga-pentixafor clinical trials
Also written [68Ga]Ga-PentixaFor.
- studies test it
- 15
- open now
- 8
- in phase 3
- 1
- first study started
- 2017
Keep track of what changes. Save the 68Ga-pentixafor studies recruiting or about to start, and get an email each week — studies that open, close, add sites or post results.
Watch these studiesHow studies write it
Studies that test it under each name
Name
Other names
Studies by the year they started
15 studies that test it; most in 2021 (3)
| Year | Studies |
|---|---|
| 2017 | 1 |
| 2019 | 1 |
| 2020 | 1 |
| 2021 | 3 |
| 2022 | 2 |
| 2023 | 3 |
| 2024 | 2 |
| 2025 | 1 |
| 2026 | 1 |
By phase
A phase 1/2 study counts in both.
- Early Phase 1
- 7
- Phase 1
- 1
- Phase 2
- 5
- Phase 3
- 1
- No phase
- 2
What it is tested for
Each study’s main condition, where its own words name it.
Who runs them
Industry 2 · Other 13
Peking Union Medical College Hospital (4) · Nantes University Hospital (2) · Pentixapharm AG (2) · Yusuf Menda (1) · Institut Cancerologie de l'Ouest (1) · National Cancer Institute (NCI) (1) · University Health Network, Toronto (1) · First Affiliated Hospital of Fujian Medical University (1)
Studies
Open first, then newest update. How each study uses 68Ga-pentixafor is read from its arms, and is right about nine times in ten.
Testing it · 15
- Evaluating the Functional Status of the Adrenal Glands With [68Ga]Ga-PentixaFor in Hyperaldosteronism and HypercortisolismRecruitingPhase 2National Cancer Institute (NCI)NCT06246357Written as [68Ga]Ga-PentixaFor
- PET/MR Scan With [68Ga]Ga-PentixaFor (CXCR4) vs Standard of Care (SOC) for Initial Staging and Follow up in Multiple Myeloma (MM)RecruitingNot applicableUniversity Health Network, TorontoNCT06871176Written as [68Ga]Ga-PentixaFor
- Value of Chemokine Receptor CXCR4 Imaging for Diagnosis and Prognostic Evaluation in Lymphoproliferative DiseasesRecruitingEarly Phase 1First Affiliated Hospital of Fujian Medical UniversityNCT04504526Written as 68Ga-Pentixafor
- Evaluation of the Value of [68Ga]Ga-PENTIXAFOR PET-CT in Patients With Metastatic Small Cell Lung Cancer (SCLC)Not yet recruitingEarly Phase 1Institut Cancerologie de l'OuestNCT07007325Written as [68Ga]Ga-PentixaFor
- In-Human CXCR4 Imaging of Hematologic and Solid Tumors Using [68Ga]-Pentixafor-PETRecruitingEarly Phase 1Memorial Sloan Kettering Cancer CenterNCT05093335Written as [68Ga]-Pentixafor
- Diagnostic Value of CXCR4-targeted PET/CT in ACTH-dependent and Independent Cushing's SyndromeRecruitingPhase 1/2Peking Union Medical College HospitalNCT07350707Written as 68Ga-Pentixafor
- CXCR4-targeted PET/CT Imaging in Hematological MalignanciesRecruitingNot applicableZhongnan HospitalNCT05255926Written as 68Ga-pentixafor
- Application of 68Ga-Pentixafor PET/CT for ThymomaRecruitingEarly Phase 1Peking Union Medical College HospitalNCT06086327Written as 68Ga-Pentixafor
- Relevance of [68Ga]Ga -PentixaFor-PET for Initial Staging and Therapeutic Evaluation of Multiple MyelomaActive, not recruitingPhase 2Nantes University HospitalNCT04561492Written as [68Ga]Ga-PentixaFor
- [68Ga]Ga-PentixaFor-PET Imaging for Staging of Marginal Zone LymphomaTerminatedPhase 3Pentixapharm AGNCT06125028Written as [68Ga]Ga-PentixaFor
- [68Ga]Ga-PentixaFor PET Imaging in CNS Lymphoma PatientsTerminatedPhase 2Pentixapharm AGNCT05222269Written as 68Ga-PTF
- Gallium 68 Pentixafor in Patients With Neuroendocrine TumorsActive, not recruitingEarly Phase 1Yusuf MendaNCT03335670Written as [68Ga]Pentixafor
- Relevance Evaluation of [68Ga]Ga-PentixaFor for Initial Staging and Detection of Minimal Residual Disease in Multiple Myeloma Patients.WithdrawnPhase 2Nantes University HospitalNCT05321862Written as [68Ga]Ga-PentixaFor
- 68Ga-pentixather and 68Ga-pentixafor PET/CT in Multiple MyelomaStatus unknownEarly Phase 1Peking Union Medical College HospitalNCT05364177Written as 68Ga-Pentixafor
- Chemokine Receptor CXCR4-targeting Molecular Imaging for Metabolic Characterization of Multiple Myeloma and LymphomaStatus unknownEarly Phase 1Peking Union Medical College HospitalNCT03436342Written as 68Ga-Pentixafor
Codes
What other systems call 68Ga-pentixafor · ClinicalTrials.gg INT000224
- MeSH (NLM) C00059768668Ga-pentixaforOne source ClinicalTrials.gov
| System | Code | Name there | Checked by |
|---|---|---|---|
| MeSH (NLM) | C000597686 | 68Ga-pentixafor | One source ClinicalTrials.gov |
Also registered as boclatixafortide (UNII TOZ93UY3AX) and gallium (68ga) boclatixafortide (UNII Y92N1ZLI87).
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.